In summary, in this study, we identified prevalent TNBC tumor mutations in HL patients, which could contribute useful information to the genomic landscape of breast cancer and provide more evidence to support the role of TP53, NOTCH, MAP3K, AKT, and PIK3CA in breast carcinogenesis. The gene discussed is TP53; the disease is breast carcinoma.